Tyman (TYMN) PT Lowered to GBX 365

Share on StockTwits

Tyman (LON:TYMN) had its price objective decreased by equities research analysts at Barclays from GBX 397 ($5.19) to GBX 365 ($4.77) in a research note issued on Thursday. The firm presently has an “overweight” rating on the stock. Barclays’ price target would suggest a potential upside of 36.70% from the stock’s previous close.

A number of other research firms also recently commented on TYMN. Liberum Capital reiterated a “buy” rating on shares of Tyman in a research report on Wednesday. Peel Hunt reiterated a “buy” rating on shares of Tyman in a research report on Wednesday, July 25th. Canaccord Genuity reiterated a “buy” rating and set a GBX 395 ($5.16) target price on shares of Tyman in a research report on Wednesday. Finally, Numis Securities upgraded Tyman to an “add” rating and increased their target price for the company from GBX 365 ($4.77) to GBX 370 ($4.83) in a research report on Thursday, July 26th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of GBX 394.17 ($5.15).

Shares of LON TYMN traded down GBX 9.50 ($0.12) during midday trading on Thursday, reaching GBX 267 ($3.49). 73,505 shares of the stock traded hands, compared to its average volume of 387,827. Tyman has a one year low of GBX 280 ($3.66) and a one year high of GBX 387 ($5.06).

About Tyman

Tyman plc, together with its subsidiaries, manufactures and supplies engineered components to the door and window industry in North America, Europe, South America, Asia, and Australasia. It operates through three divisions: AmesburyTruth, ERA, and SchlegelGiesse. The AmesburyTruth division manufactures window and door hardware components, extrusions, and sealing systems.

Read More: Penny Stocks

Analyst Recommendations for Tyman (LON:TYMN)

Receive News & Ratings for Tyman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyman and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.